(SECT-B) Sectra (publ) - Performance 33.3% in 12m
Compare SECT-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
70.82%
#10 in Group
Rel. Strength
85.44%
#1164 in Universe
Total Return 12m
33.26%
#25 in Group
Total Return 5y
243.28%
#9 in Group
P/E 111
97th Percentile in Group
P/E Forward 71.9
86th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 1.45%
82th Percentile in Group
12m Total Return: SECT-B (33.3%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: SECT-B vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for SECT-B
Total Return (including Dividends) | SECT-B | XLV | S&P 500 |
---|---|---|---|
1 Month | 9.05% | -7.37% | -5.89% |
3 Months | 9.66% | -4.55% | -12.45% |
12 Months | 33.26% | -0.54% | 6.72% |
5 Years | 243.28% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | SECT-B | XLV | S&P 500 |
1 Month | 16.6% | -82.6% | -74.5% |
3 Months | -3.70% | -37.8% | -88.2% |
12 Months | 42.2% | -1.6% | 66.1% |
5 Years | 80.4% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #11 | 17.7% | 15.9% |
3 Month | #22 | 14.9% | 25.3% |
12 Month | #26 | 34.0% | 24.9% |
5 Years | #8 | 134% | 70.7% |
FAQs
Does SECT-B Sectra (publ) outperforms the market?
Yes,
over the last 12 months SECT-B made 33.26%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months SECT-B made 9.66%, while XLV made -4.55%.
Over the last 3 months SECT-B made 9.66%, while XLV made -4.55%.
Performance Comparison SECT-B vs Indeces and Sectors
SECT-B vs. Indices SECT-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 10.4% | 14.9% | 3.72% | 26.5% |
US NASDAQ 100 | QQQ | 11.2% | 15.3% | 4.25% | 27.7% |
US Dow Jones Industrial 30 | DIA | 11.5% | 14.9% | 3.18% | 28.0% |
German DAX 40 | DAX | 5.01% | 18.5% | -13.3% | 15.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | 9.66% | 16.6% | 1.44% | 27.4% |
Hongkong Hang Seng | HSI | 6.08% | 18.9% | 2.20% | 17.0% |
India NIFTY 50 | INDA | 6.00% | 4.28% | 1.27% | 30.2% |
Brasil Bovespa | EWZ | 6.81% | 14.1% | 0.77% | 42.7% |
SECT-B vs. Sectors SECT-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 10.1% | 14.7% | -5.09% | 19.7% |
Consumer Discretionary | XLY | 11.2% | 13.0% | 0.98% | 24.0% |
Consumer Staples | XLP | 7.07% | 5.85% | -6.50% | 19.3% |
Energy | XLE | 5.65% | 19.1% | 2.66% | 43.6% |
Financial | XLF | 9.0% | 13.6% | -4.40% | 14.3% |
Health Care | XLV | 9.97% | 16.4% | 5.12% | 33.8% |
Industrial | XLI | 9.25% | 13.8% | 3.64% | 27.9% |
Materials | XLB | 8.65% | 15.7% | 10.8% | 40.8% |
Real Estate | XLRE | 5.03% | 11.9% | 2.37% | 16.2% |
Technology | XLK | 11.7% | 18.0% | 10.5% | 34.5% |
Utilities | XLU | 7.06% | 9.47% | -2.02% | 8.89% |
Aerospace & Defense | XAR | 8.68% | 9.01% | -6.04% | 9.10% |
Biotech | XBI | 6.81% | 20.9% | 18.3% | 42.2% |
Homebuilder | XHB | 9.42% | 15.9% | 21.6% | 42.4% |
Retail | XRT | 8.67% | 11.2% | 8.39% | 37.7% |